BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30642398)

  • 1. Risk stratification models in human papillomavirus-associated oropharyngeal squamous cell carcinoma: the Nova Scotia distribution.
    Forner D; Rigby MH; Wilke D; Taylor SM; Lamond N
    J Otolaryngol Head Neck Surg; 2019 Jan; 48(1):3. PubMed ID: 30642398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis.
    Weinberger PM; Yu Z; Haffty BG; Kowalski D; Harigopal M; Brandsma J; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A
    J Clin Oncol; 2006 Feb; 24(5):736-47. PubMed ID: 16401683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of Cervical Lymph Node Metastases From Squamous Cell Carcinoma of the Oropharynx in the Era of Risk Stratification Using Human Papillomavirus and Smoking Status.
    Amsbaugh MJ; Yusuf M; Cash E; Silverman C; Wilson E; Bumpous J; Potts K; Perez C; Bert R; Redman R; Dunlap N
    Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):349-353. PubMed ID: 27598805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of human papillomavirus and survival in oropharyngeal cancer other than tonsil or base of tongue cancer.
    Marklund L; Näsman A; Ramqvist T; Dalianis T; Munck-Wikland E; Hammarstedt L
    Cancer Med; 2012 Aug; 1(1):82-8. PubMed ID: 23342257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.
    Habbous S; Chu KP; Qiu X; La Delfa A; Harland LT; Fadhel E; Hui A; Perez-Ordonez B; Weinreb I; Liu FF; Waldron J; O'Sullivan B; Goldstein D; Xu W; Huang SH; Liu G
    Cancer Epidemiol; 2013 Dec; 37(6):820-9. PubMed ID: 24184275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus in oropharyngeal cancer in Canada: analysis of 5 comprehensive cancer centres using multiple imputation.
    Habbous S; Chu KP; Lau H; Schorr M; Belayneh M; Ha MN; Murray S; O'Sullivan B; Huang SH; Snow S; Parliament M; Hao D; Cheung WY; Xu W; Liu G
    CMAJ; 2017 Aug; 189(32):E1030-E1040. PubMed ID: 28808115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of human papilloma virus (HPV) infections in oral squamous cell carcinomas: a retrospective analysis of 88 patients and literature overview.
    Krüger M; Pabst AM; Walter C; Sagheb K; Günther C; Blatt S; Weise K; Al-Nawas B; Ziebart T
    J Craniomaxillofac Surg; 2014 Oct; 42(7):1506-14. PubMed ID: 24947612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus prevalence and prognostic implication in oropharyngeal squamous cell carcinomas.
    Melkane AE; Auperin A; Saulnier P; Lacroix L; Vielh P; Casiraghi O; Msakni I; Drusch F; Temam S
    Head Neck; 2014 Feb; 36(2):257-65. PubMed ID: 23728782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus in oropharyngeal squamous cell carcinoma in South-Eastern Norway: prevalence, genotype, and survival.
    Fossum GH; Lie AK; Jebsen P; Sandlie LE; Mork J
    Eur Arch Otorhinolaryngol; 2017 Nov; 274(11):4003-4010. PubMed ID: 28933005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus DNA detection in fine-needle aspirates as indicator of human papillomavirus-positive oropharyngeal squamous cell carcinoma: A prospective study.
    Sivars L; Landin D; Haeggblom L; Tertipis N; Grün N; Bersani C; Marklund L; Ghaderi M; Näsman A; Ramqvist T; Nordfors C; Munck-Wikland E; Tani E; Dalianis T
    Head Neck; 2017 Mar; 39(3):419-426. PubMed ID: 27898186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synchronous cancers in patients with head and neck cancer: risks in the era of human papillomavirus-associated oropharyngeal cancer.
    Jain KS; Sikora AG; Baxi SS; Morris LG
    Cancer; 2013 May; 119(10):1832-7. PubMed ID: 23423883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squamous cell carcinoma metastatic to neck from an unknown primary: the potential impact of modern pathologic evaluation on perceived incidence of human papillomavirus-positive oropharyngeal carcinoma prior to 1970.
    Chenevert J; Seethala RR; Barnes EL; Chiosea SI
    Laryngoscope; 2012 Apr; 122(4):793-6. PubMed ID: 22252715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of p16 expression in oropharyngeal cancer in the postoperative setting: the necessity of re-evaluating traditional risk stratification.
    Lee J; Chang JS; Kwon HJ; Kim SH; Shin SJ; Keum KC
    Jpn J Clin Oncol; 2016 Oct; 46(10):911-918. PubMed ID: 27474125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different prognostic models for different patient populations: validation of a new prognostic model for patients with oropharyngeal cancer in Western Europe.
    Rietbergen MM; Witte BI; Velazquez ER; Snijders PJ; Bloemena E; Speel EJ; Brakenhoff RH; Kremer B; Lambin P; Leemans CR
    Br J Cancer; 2015 May; 112(11):1733-6. PubMed ID: 25950384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A different entity: a population based study of characteristics and recurrence patterns in oropharyngeal squamous cell carcinomas.
    Murray S; Ha MN; Thompson K; Hart RD; Rajaraman M; Snow SL
    J Otolaryngol Head Neck Surg; 2015 Aug; 44(1):30. PubMed ID: 26310237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
    Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
    Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining molecular phenotypes of human papillomavirus-associated oropharyngeal squamous cell carcinoma: validation of three-class hypothesis.
    Weinberger PM; Yu Z; Kountourakis P; Sasaki C; Haffty BG; Kowalski D; Merkley MA; Rimm DL; Camp RL; Psyrri A
    Otolaryngol Head Neck Surg; 2009 Sep; 141(3):382-9. PubMed ID: 19716018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
    Haughey BH; Sinha P
    Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990-2009).
    Rodrigo JP; Heideman DA; García-Pedrero JM; Fresno MF; Brakenhoff RH; Díaz Molina JP; Snijders PJ; Hermsen MA
    Int J Cancer; 2014 Jan; 134(2):487-92. PubMed ID: 23824638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of Japanese oropharyngeal squamous cell carcinoma positive for human papillomavirus infection.
    Nomura F; Sugimoto T; Kitagaki K; Ito T; Kawachi H; Eishi Y; Watanabe K; Igaue M; Shimizu N; Tomita M; Kitamura K; Kishimoto S
    Acta Otolaryngol; 2014 Dec; 134(12):1265-74. PubMed ID: 25399886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.